justbacked

Biotechnology, Genetics, Health Diagnostics, Life Science

Element Biosciences

Element Biosciences raised a Series E announced on Jun 9, 2026, led by RA Capital Management, Samsung Electronics, Janus Henderson Investors, Wellington Management, Venrock. Since then it has posted 24 roles (13 still open), the first 7 days after it. Another 1 open role was posted before the announcement. With 14 open roles it is hiring more than 22% of the 67 Series D+ startups on JustBacked (median: 48). In total it has raised $678M over 6 rounds from 15 investors.

Roles posted per month since the round
  • June 20261
  • July 20261
  • August 20265
  • September 20267
  • October 20265
  • November 20265

From Element Biosciences's own hiring system, by posting date. Tracked since Oct 4, 2026; roles that closed before then aren't counted.

Element Biosciences develops genomic sequencing and multiomics technologies used in drug discovery, and diagnostic applications.

Why join Element Biosciences?

Drug developers and diagnostics labs depend on sequencers, so if cheaper, faster reads become the standard, that could reshape a big chunk of life science. Element Biosciences, a San Diego sequencing company, has raised $678M over six rounds, with RA Capital, Samsung Electronics and Janus Henderson among its backers. Its Series E closed in June, and the 15 open roles split across engineering (4), sales (3) and other (3).

JustBacked's take, based on Element Biosciences's own site and its funding and hiring data.

Series E · 165d agoelementbiosciences.com

Hiring velocity

Open roles
14
Added, 30 days
+6
Added, 7 days
+1
Closed, 30 days
8
Raised
165 days ago
Led by
RA Capital Management, Samsung Electronics, Janus Henderson Investors, Wellington Management, Venrock
Team size
251-500
HQ
San Diego, California, United States
Newest role
4d ago
Tracked since
Oct 4, 2026

Where they're hiring

Hardware3
Engineering3
Sales & BD2
Science2
Data & ML1
Legal1

Open roles at Element Biosciences

Source: elementbiosciences.com, checked daily.